Genta-Aventis Case Study: Failing Strategies Within Late Stage Vertical Licensing
| Format: | Elektroniczne Czasopismo |
|---|---|
| Język: | angielski |
| Wydane: |
MarketLine, a Progressive Digital Media business
|
| Dostęp online: | Full text available on EBSCOhost[Nov 2005-Nov 2005 |
Podobne zapisy
IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
Roche-Kosan Case Study: Successful Early Licensing Strategies
Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
Aventis SWOT Analysis
Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio
Sanofi-Aventis SWOT Analysis
Licensing Loyalty
od: McLeod
od: McLeod
License to Play
od: Daliot-Bul
od: Daliot-Bul
License to Wed
od: Richman
od: Richman
Licensing Journal
Failing Families, Failing Science
od: Lincoln
od: Lincoln
Licensed Practical Nurse
Vertical Reefs
od: Wicksten
od: Wicksten
Lipitor Case Study: Lifecycle Management Strategies
Failed Frontiersmen
od: Donahue
od: Donahue
Words Fail
od: Dickinson
od: Dickinson
The Revolution that Failed
od: Fairclough
od: Fairclough
Failed Evidence
od: Harris
od: Harris
Failed Promises
od: Konisky
od: Konisky
IPO Exit Strategies Case Study: Undertaking a Successful IPO Exit Strategy
Staging Harmony
od: Brokaw
od: Brokaw
Staging Asia
od: Kuruppath
od: Kuruppath
Setting the Stage
od: Hays
od: Hays
Subversive Stages
od: Komporaly
od: Komporaly
Staging Revolution
od: Fan
od: Fan
Occupying the Stage
od: Bredeson
od: Bredeson
Staging Family
od: Mullenneaux
od: Mullenneaux
Staging the Amistad
od: Christensen
od: Christensen
On Stage Alone
od: Gitelman
od: Gitelman
Staging Ghana
od: Schauert
od: Schauert
Stage for Action
od: Dail
od: Dail
The Stages of Memory
od: Young
od: Young
Podobne zapisy
- IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
- Roche-Kosan Case Study: Successful Early Licensing Strategies
- Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
- Aventis SWOT Analysis
- Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio